Home/Filings/4/0001061983-22-000028
4//SEC Filing

SCHLOSSBERG MARK A 4

Accession 0001061983-22-000028

CIK 0001061983other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 7:48 PM ET

Size

6.4 KB

Accession

0001061983-22-000028

Insider Transaction Report

Form 4
Period: 2022-02-16
SCHLOSSBERG MARK A
SVP - Legal & General Counsel
Transactions
  • Award

    Common Stock

    2022-02-16+1,90052,750 total
  • Award

    Common Stock

    2022-02-16+3,12555,875 total
Footnotes (2)
  • [F1]On or about May 11, 2021, the Reporting Person was granted performance-based stock units (PSUs) of the Issuer, which upon satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into fully-vested shares of common stock of the Issuer.
  • [F2]Comprised of restricted stock units (RSUs) issued upon conversion of certain PSUs granted to the Reporting Person on May 11, 2021. The satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into RSUs of the Issuer. These RSUs will vest in whole on February 16, 2023.

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001520533

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:48 PM ET
Size
6.4 KB